Arginine Supplementation Targeting Tumor-Killing Immune Cells Reconstructs the Tumor Microenvironment and Enhances the Antitumor Immune Response | ACS Nano
Cancers | Free Full-Text | Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects
Cells | Free Full-Text | Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?
Frontiers | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Systemic immunity in cancer | Nature Reviews Cancer
Immune-Cell-Derived Exosomes for Cancer Therapy | Molecular Pharmaceutics
Frontiers | Research progress in inducing immunogenic cell death of tumor cells
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy | Signal Transduction and Targeted Therapy
Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma | Genes & Immunity
Cells | Free Full-Text | The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
IJMS | Free Full-Text | Autoimmune Responses in Oncology: Causes and Significance
The Contribution of Epigenetics to Cancer Immunotherapy: Trends in Immunology
Immune-checkpoint inhibitors: long-term implications of toxicity | Nature Reviews Clinical Oncology
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer | Scientific Reports
Laboratory biomarkers of an effective antitumor immune response. Clinical significance. - ScienceDirect
Frontiers | What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
Frontiers | The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
Nanoparticle-Based Immunotherapy for Cancer | ACS Nano
Cancers | Free Full-Text | NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models
Frontiers | Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
Elevated tumor markers for monitoring tumor response to immunotherapy - ScienceDirect
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing: Molecular Therapy - Methods & Clinical Development
DNA Methylation and Anticancer Drug Resistance in Gynecological Tumors
